September 1, 2009 – Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER sirolimus-eluting coronary stent.

The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, Ark.

September 1, 2009 – St. Jude Medical Inc. today announced European launch of the next generation version 4.0 of its Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

September 1, 2009 – Sanofi-aventis said Sunday the investigational anti-Xa intravenous anti-coagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in four out of the five otamixaban tested doses, versus standard UFH/eptifibatide combination in (non-ST) ACS patients suitable for

September 1, 2009 - BioClinica Inc., a clinical trial services provider, today announced that it has acquired the CardioNow unit of Agfa HealthCare to offer streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials as part of its suite of imaging services.


September 1, 2009 – AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study of Platelet Inhibition and Patient Outcomes), which demonstrate that ticagrelor (BRILINTA) has achieved greater efficacy in the primary endpoint, reduction of cardiovascular events (CV death, MI, stroke) over clopidogrel (Plavix/Iscover ) (9.8 vs.

September 1, 2009 – Toshiba America Medical Systems Inc. will demonstrate its Next Generation Advanced Image Processing (AIP) feature, available on the Infinix-i product line at this year’s Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium.

September 1, 2009 – Echocardiography with Doppler is the method of choice for the noninvasive evaluation of prosthetic valves, according to a new guideline document in the September issue of the Journal of the American Society of Echocardiography (JASE).

September 1, 2009 – CardioDx said last week it successfully completed its multicenter validation study for Corus CAD, the first gene expression test to quantify the likelihood of obstructive(1) coronary artery disease (CAD) in patients with stable chest pain.

September 1, 2009 – GE Healthcare and 2D/3D/4D imaging company TomTec Imaging Systems GmbH entered into a formal strategic cooperation contract to boost their excellence in echocardiography.

August 31, 2009 – IDEV Technologies Inc. announced last week the first patient was enrolled in the company's FDA-approved multicenter clinical trial of its self-expanding SUPERA stent for the treatment of biliary and peripheral artery disease (PAD) in the superficial femoral artery (SFA).

Subscribe to
Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now